Swiss National Bank Pro Qr Therapeutics N.V. Transaction History

Swiss National Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 06, 2020	SELL	$5.84 - $10.51 $298,424 - $537,061	-51,100 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$5.76 - $9.44 $11,520 - $18,880	2,000 Added 4.07%	51,100 $294,000
Q2 2019 Aug 02, 2019	BUY	$9.1 - $15.55 $22,750 - $38,875	2,500 Added 5.36%	49,100 $447,000
Q4 2018 Feb 13, 2019	BUY	$15.25 - $22.4 $710,650 - $1.04 Million	46,600 New	46,600 $735,000

17.4M

37.7K

21.3K

Ticker PRQR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,362,096
Market Cap $285M
Description
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.